The COVID-19 pandemic has underscored the critical importance of molecular diagnosis as a cornerstone in the battle against infectious diseases. Moreover, in the field of oncology, molecular diagnosis empowers clinicians to pinpoint specific genetic mutations and biomarkers linked with various cancer types. These tests not only facilitate the prevention of further spread but also enable tailored treatment strategies, thereby enhancing patient outcomes, mitigating the risk of unnecessary therapies, and reducing the burden on our healthcare system.

Additionally, rapid and precise molecular diagnosis holds immense potential for farmers in averting substantial operational losses caused by pathogens.

In this pursuit, we remain steadfast in our commitment to advancing healthcare outcomes in both human and animal health through new product innovation.